News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
54 Results
Type
Article (14)
Press Release (40)
Section
Business (17)
Deals (5)
Drug Development (8)
News (28)
Tag
Alliances (3)
Clinical research (6)
Earnings (10)
Events (17)
IPO (4)
Mergers & acquisitions (1)
People (4)
Phase II (3)
Phase III (3)
Preclinical (2)
Date
Last 365 days (1)
2024 (1)
2022 (4)
2021 (14)
2020 (3)
2019 (19)
2018 (2)
2017 (3)
2016 (1)
2014 (3)
2013 (2)
2012 (2)
54 Results for "discuva".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd.
Under the deal, Summit acquired 100% of the issued share capital of Discuva.
December 27, 2017
·
9 min read
Discuva Release: Company Awarded Innovate UK Grant to Develop New Antibiotics To Address Multidrug Resistance
January 25, 2017
·
3 min read
Business
Discuva Announces Extension Of Ongoing Pharma Collaboration To Combat Life-Threatening Infections Caused By Multi-Drug Resistant Bacteria
February 21, 2017
·
3 min read
Business
Roche, Discuva In Up To $191 Million+ Antibacterial Collaboration
February 28, 2014
·
1 min read
Genetown
Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conference
Summit Therapeutics Inc. today announced that it will present the Company’s vision and its intended future development pathways at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at approximately 3:45 PM EST.
January 5, 2022
·
4 min read
Business
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the fourth quarter and year-ended December 31, 2023.
February 20, 2024
·
22 min read
Business
Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte Gayko
Summit Therapeutics Inc. today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors, effective immediately.
November 3, 2021
·
6 min read
Business
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the third quarter and nine months ended September 30, 2021.
November 15, 2021
·
23 min read
Genetown
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
Summit Therapeutics Inc. invites our shareholders and other interested parties to attend our Company’s Annual Shareholders’ Meeting, which will be held virtually on Wednesday, June 16, 2021, at 1:00 pm Eastern Time.
June 3, 2021
·
4 min read
Business
Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of Directors
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Kenneth A. Clark, JD, has been appointed to our Board of Directors, effective immediately.
October 8, 2021
·
7 min read
1 of 6
Next
